Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Biotherapy in Rheumatoid Aarthritis and Spondyloarthritis. A Clinical Multicentric Study: Biologic National Registry (BINAR)

NCT03793660 is registered in ClinicalTrials.gov with Dacima Consulting as lead sponsor.

NCT NCT03793660
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03793660 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Biotherapy in Rheumatoid Aarthritis and Spondyloarthritis. A Clinical Multicentric Study: Biologic National Registry (BINAR)
Lead sponsor
Dacima Consulting
Phase
Observational
Overall status
Completed
Start date
May 23, 2018
Completion date
June 30, 2022
Enrollment
439 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

arthritis, rheumatoid, spondylitis